Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers

NCT04459273 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Bladder Carcinoma
Cervical Carcinoma
Cholangiocarcinoma
Hematopoietic and Lymphoid Cell Neoplasm
Hepatocellular Carcinoma
Malignant Adrenal Gland Neoplasm
Malignant Brain Neoplasm
Malignant Pleural Neoplasm
Malignant Skin Neoplasm
Malignant Solid Neoplasm
Malignant Testicular Neoplasm
Malignant Thymus Neoplasm
Neuroendocrine Neoplasm
Thyroid Gland Carcinoma
Urothelial Carcinoma
Cancer of Unknown Primary Site

Interventions

PROCEDURE: Computed Tomography
DRUG: Gallium Ga 68 FAPi-46
PROCEDURE: Positron Emission Tomography
RADIATION: 18F-FDG

Sponsor

Jonsson Comprehensive Cancer Center